1441 studies found for:    Alzheimer's
Show Display Options
Rank Status Study
21 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
22 Active, not recruiting Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
23 Recruiting What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?
Condition: Alzheimer Disease
Intervention: Other: neuropsychological assessment
24 Active, not recruiting MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
Condition: Alzheimer Disease
Interventions: Drug: RO4602522;   Drug: RO4601522;   Drug: placebo;   Drug: donepezil;   Drug: rivastigmine;   Drug: galantamine;   Drug: memantine
25 Completed
Has Results
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol;   Drug: Memantine;   Drug: Placebo
26 Unknown  Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: donepezil
27 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
28 Recruiting Study of the Safety & Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor (Leukine) in the Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Sagramostim;   Drug: Saline -- placebo comparator
29 Completed Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg
30 Completed Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
31 Unknown  Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
32 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
33 Completed Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
34 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
35 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
36 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
37 Completed Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
38 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
39 Completed
Has Results
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine 5 and 10 cm^2 patch
40 Completed
Has Results
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases
Interventions: Drug: EVP-6124 (0.1 mg/day);   Drug: EVP-6124 (0.3 mg/day);   Drug: EVP-6124 (1.0 mg/day);   Drug: Comparator: Placebo;   Drug: Donepezil;   Drug: Rivastigmine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years